RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Ikena Oncology ROA 2024

Ikena Oncology ROA

-0.35

Ikena Oncology Dividend yield

Ticker

IKNA

ISIN

US45175G1085

In 2024, Ikena Oncology's return on assets (ROA) was -0.35, a -11.09% increase from the -0.4 ROA in the previous year.

Ikena Oncology Aktienanalyse

What does Ikena Oncology do?

Ikena Oncology Inc is a biopharmaceutical company specializing in the development and research of drugs for the treatment of cancer. The company was founded in 2016 and is headquartered in Boston, Massachusetts. Ikena Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Ikena Oncology's Return on Assets (ROA)

Ikena Oncology's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Ikena Oncology's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Ikena Oncology's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Ikena Oncology’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Ikena Oncology Stock

What is the Return on Assets (ROA) of Ikena Oncology this year?

The Return on Assets (ROA) of Ikena Oncology is -0.35 undefined this year.

What was the ROA of Ikena Oncology compared to the previous year?

The ROA of Ikena Oncology has increased by -11.09% compared to the previous year.

What consequences do high ROA have for investors of Ikena Oncology?

A high ROA is advantageous for investors of Ikena Oncology, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Ikena Oncology?

A low ROA can be unfavorable for investors of Ikena Oncology as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Ikena Oncology affect the company?

An increase in ROA of Ikena Oncology can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Ikena Oncology impact the company?

A reduction in the ROA of Ikena Oncology can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Ikena Oncology?

Some factors that can influence the ROA of Ikena Oncology include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Ikena Oncology important for investors?

The ROA of Ikena Oncology is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Ikena Oncology take to improve ROA?

To improve ROA, Ikena Oncology can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Ikena Oncology pay?

Over the past 12 months, Ikena Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ikena Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Ikena Oncology?

The current dividend yield of Ikena Oncology is .

When does Ikena Oncology pay dividends?

Ikena Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ikena Oncology?

Ikena Oncology paid dividends every year for the past 0 years.

What is the dividend of Ikena Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ikena Oncology located?

Ikena Oncology is assigned to the '-' sector.

Wann musste ich die Aktien von Ikena Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ikena Oncology from 6/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/4/2024.

When did Ikena Oncology pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Ikena Oncology in the year 2023?

In the year 2023, Ikena Oncology distributed 0 USD as dividends.

In which currency does Ikena Oncology pay out the dividend?

The dividends of Ikena Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ikena Oncology

Our stock analysis for Ikena Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ikena Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.